HMGB1
免疫系统
癌症免疫疗法
癌症研究
免疫疗法
免疫
调解人
促炎细胞因子
肿瘤微环境
炎症
免疫学
癌症
生物
化学
细胞生物学
遗传学
作者
Jinlin Wen,Xinyan Zhang
标识
DOI:10.31083/j.fbl2810260
摘要
Tumor immunity is a cycle that begins with the release of antigens from tumor cells and ends with the destruction of tumor cells. High mobility group box 1 (HMGB1) is a nonhistone protein widely present in the nucleus of mammalian cells and can be released by immune cells or tumor cells. As a proinflammatory mediator or alarm protein, the activity and function of HMGB1 are determined by the environment, binding receptors, redox status and posttranslational modifications (PTMs), and HMGB1 plays a key role in inflammation and tumor immune processes. In this review, we summarize in detail the current studies on the dual role of HMGB1 in tumor immunity, focusing mainly on immunosuppressive effects, such as regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs), as well as antitumor immunoenhancement effects, such as immunogenic cell death (ICD). Finally, we discuss the potential and challenges of HMGB1 in antitumor immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI